Medline ® Abstract for Reference 61
of 'Interferon-gamma release assays for diagnosis of latent tuberculosis infection'
61
TI
A summary of meeting proceedings on addressing variability around the cut point in serial interferon-γrelease assay testing.
AU
Daley CL, Reves RR, Beard MA, Boyle J, Clark RB, Beebe JL, Catanzaro A, Chen L, Desmond E, Dorman SE, Hudson TW, Lardizabal AA, Kapoor H, Marder DC, Miranda C, Narita M, Reichman L, Schwab D, Seaworth BJ, Terpeluk P, Thanassi W, Kawamura LM
SO
Infect Control Hosp Epidemiol. 2013 Jun;34(6):625-30. Epub 2013 Apr 19.
On June 13, 2012, a group of key stakeholders, leaders, and national experts on tuberculosis (TB), occupational health, and laboratory science met in Atlanta, Georgia, to focus national discussion on the higher than expected positive results occurring among low-risk, unexposed healthcare workers undergoing serial testing with interferon-γrelease assays (IGRAs). The objectives of the meeting were to present the latest clinical and operational research findings on the topic, to discuss evaluation and treatment algorithms that are emerging in the absence of national guidance, and to develop a consensus on the action steps needed to assist programs and physicians in the interpretation of serial testing IGRA results. This report summarizes its proceedings.
AD
Department of Medicine, National Jewish Health, Denver, Colorado 80206, USA. daleyc@njhealth.org
PMID